Csenge Advisory Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.33M | Sell |
3,471
-26
| -0.7% | -$9.98K | 0.07% | 217 |
|
2025
Q1 | $1.48M | Buy |
3,497
+87
| +3% | +$36.9K | 0.08% | 189 |
|
2024
Q4 | $1.26M | Sell |
3,410
-1,250
| -27% | -$461K | 0.07% | 221 |
|
2024
Q3 | $2.34M | Buy |
4,660
+592
| +15% | +$297K | 0.12% | 137 |
|
2024
Q2 | $2.2M | Buy |
4,068
+77
| +2% | +$41.7K | 0.13% | 126 |
|
2024
Q1 | $2.07M | Sell |
3,991
-51
| -1% | -$26.4K | 0.12% | 140 |
|
2023
Q4 | $1.91M | Sell |
4,042
-155
| -4% | -$73.1K | 0.12% | 151 |
|
2023
Q3 | $1.83M | Buy |
4,197
+238
| +6% | +$104K | 0.12% | 140 |
|
2023
Q2 | $1.76M | Sell |
3,959
-154
| -4% | -$68.4K | 0.12% | 143 |
|
2023
Q1 | $1.89M | Buy |
4,113
+77
| +2% | +$35.4K | 0.14% | 133 |
|
2022
Q4 | $2.07M | Sell |
4,036
-135
| -3% | -$69.3K | 0.16% | 119 |
|
2022
Q3 | $1.9M | Sell |
4,171
-231
| -5% | -$105K | 0.16% | 123 |
|
2022
Q2 | $2.12M | Buy |
4,402
+534
| +14% | +$258K | 0.18% | 109 |
|
2022
Q1 | $1.9M | Buy |
3,868
+591
| +18% | +$290K | 0.15% | 123 |
|
2021
Q4 | $1.26M | Sell |
3,277
-24
| -0.7% | -$9.21K | 0.11% | 156 |
|
2021
Q3 | $1.24M | Buy |
3,301
+24
| +0.7% | +$9.02K | 0.1% | 176 |
|
2021
Q2 | $1.26M | Buy |
3,277
+2,588
| +376% | +$994K | 0.11% | 156 |
|
2021
Q1 | $249K | Sell |
689
-247
| -26% | -$89.3K | 0.03% | 427 |
|
2020
Q4 | $301K | Sell |
936
-17
| -2% | -$5.47K | 0.04% | 321 |
|
2020
Q3 | $270K | Sell |
953
-1,120
| -54% | -$317K | 0.04% | 313 |
|
2020
Q2 | $545K | Sell |
2,073
-140
| -6% | -$36.8K | 0.08% | 177 |
|
2020
Q1 | $502K | Buy |
2,213
+872
| +65% | +$198K | 0.13% | 142 |
|
2019
Q4 | $405K | Buy |
1,341
+383
| +40% | +$116K | 0.1% | 185 |
|
2019
Q3 | $230K | Buy |
+958
| New | +$230K | 0.06% | 234 |
|
2018
Q4 | – | Sell |
-53
| Closed | -$14K | – | 555 |
|
2018
Q3 | $14K | Buy |
+53
| New | +$14K | 0.01% | 436 |
|